IP Library › Granted Patent US 10,799,150
Granted Patent B2
US 10,799,150 · App. 16/065,103 · Granted Oct 13, 2020

Image based bilirubin determination

Inventors: Gunnar Vartdal (Trondheim, NO); Lise Lyngsnes Randeberg (Trondheim, NO); Anders Aune (Trondheim, NO); Aleksander Kringstad (Trondheim, NO)
Assignee: PICTERUS AS
A61B5/1034A61B5/1455A61B5/14546A61B5/4244G16H30/20G16H30/40G16H50/20G16H50/50A61B2503/045A61B2505/03A61B2560/0242
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,799,150
App. No.
16/065,103
Granted
Oct 13, 2020
Kind
B2
Abstract

The invention relates to diagnosis in general and more specifically a system and a method for determining the presence of jaundice in newborn babies, also known as neonatal jaundice. A main objective of the present invention is to provide a simple system and method for determining the presence of jaundice. Particularly since most deaths due to jaundice occur in low-income countries, there is a large unmet need of simple, reliable and affordable technologies able to identify at-risk newborn. The objective is accomplished through receiving a depiction of skin from an RGB sensor, and then using either an optical diffusion model of the skin or Monte Carlo simulations to calculate the bilirubin concentration. A meta model of the optical diffusion model or Monte Carlo simulations can also be used. Colour calibration is also performed by e.g. thin-plate spline interpolation.

Claims (27)

1. A method for estimating a level of bilirubin in blood causing jaundiced skin in a subject, the method comprising:

receiving a depiction of skin using an RGB sensor, and

determining a level of bilirubin in the depiction by comparing simulated skin colors of known bilirubin concentration with the received depiction, wherein the simulated skin colors are obtained by using one of, an optical diffusion model of a skin and Monte Carlo simulations of skin optics.

2. The method according to claim 1 , wherein the depiction of skin is further color calibrated using a color calibration chart.

3. A method for determining a rate of change in a level of bilirubin in blood causing jaundiced skin and sclera, the method comprising:

receiving a depiction of jaundiced skin and sclera using an RGB sensor,

calculating a level of bilirubin for skin and sclera in the received depiction by comparing simulated skin colors of known bilirubin concentration with the received depiction, wherein the simulated skin colors are obtained by using one of, an optical diffusion model of a skin and Monte Carlo simulations of skin optics,

comparing the calculated level of bilirubin from the skin with the calculated level of bilirubin from the sclera, and

determining a rate of change in the level of bilirubin in the blood by the difference in the indicated level of bilirubin from the skin to the indicated level of bilirubin from the sclera.

4. An apparatus for estimating a level of bilirubin in blood causing jaundiced skin in a subject, the apparatus comprising:

a receiving device configured to receive a depiction of skin using an RGB sensor,

a calculating device configured to calculate simulated skin colors by using one of, an optical diffusion model of a skin and Monte Carlo simulations of skin optics, and

a determining device configured to determine a level of bilirubin concentration in the blood by comparing the calculated simulated skin colors with the received depiction.

5. The apparatus according to claim 4 , wherein the depiction further comprises a color calibration chart for color calibration of the depiction.

6. The method according to claim 2 , wherein the calibration chart comprises a plurality of color patches and wherein the color patches are printed using spectral printing.

7. The method according to claim 6 , wherein the calibration chart further comprises an opening through which the skin or sclera is visible.

8. The method according to claim 7 , wherein the calibration chart further comprises a plurality of grey patches for detecting the variations of illumination of the calibration chart.

9. The method according to claim 8 , wherein the grey patches are evenly distributed over the calibration chart.

10. The method according to claim 8 , wherein at least one of the plurality of grey patches is arranged at a corner of the calibration chart.

11. The method according to claim 7 , wherein at least one of the plurality of grey patches is colored with a simulated skin color with a corresponding bilirubin concentration.

12. The apparatus according to claim 5 , wherein the calibration chart comprises a plurality of color patches, wherein the color patches on the calibration chart are printed using spectral printing.

13. The apparatus according to claim 12 , wherein the calibration chart further comprises an opening through which the skin or sclera is visible.

14. The apparatus according to claim 13 , further comprising a plurality of grey patches for detecting the variations of illumination of the calibration chart.

15. The apparatus according to claim 14 , wherein the grey patches are evenly distributed over the calibration chart.

16. The apparatus according to claim 14 , wherein at least one grey patch is arranged at a corner of the calibration chart.

17. The apparatus according to claim 15 , wherein at least one of the plurality of grey patches is arranged at a corner of the calibration chart.

18. The apparatus according to claim 5 , wherein at least one patch is colored with a simulated skin color with a corresponding bilirubin concentration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: VARTDAL, GUNNAR; RANDEBERG, LISE LYNGSNES; AUNE, ANDERS; KRINGSTAD, ALEKSANDER
To: PICTERUS AS
Reel/Frame 049600/0264 →
Priority Claims (1)
NO 20151783 · Dec 22, 2015 · national
Continuity (1)
Related Publication 20190343426A1 · Nov 14, 2019